Trial intelligence / Profile preview

WF10 in Diabetic Foot Ulcer Patients

NCT04372355Phase 2Completed

Sponsor
Srinakharinwirot University
Start
Jun 2019
Primary completion
Apr 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of tetrachlorodecaoxide in diabetic foot ulcer (DFU), sponsored by Srinakharinwirot University. Started Jun 2019; status: completed.

02

Drugs

tetrachlorodecaoxide
03

Conditions

diabetic foot ulcer (DFU)

Beyond the preview

Go deeper on NCT04372355.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04372355.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call